Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TMX-67 (febuxostat) in pediatric hyperuricemia with or without gout
jRCT2080224075Phase 2Completed
- Sponsor
- Teijin Pharma
- Start
- Oct 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of febuxostat in hyperuricemia and gout, sponsored by Teijin Pharma. Started Oct 2018; status: completed.
02
Drugs
febuxostat
03
Conditions
hyperuricemiagout
Beyond the preview
Go deeper on jRCT2080224075.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224075.